Bristol-Myers Squibb
BMY
$44.70
Share price
-8.51%
Change (1 day)
-36.63%
Change (1 year)
Categories
Operating Margin for Bristol-Myers Squibb (BMY)
Operating Margin as of April 2024 (TTM): 19.24%
According to Bristol-Myers Squibb's latest financial reports and stock price the company's current Operating Margin is 19.24%. At the end of 2022 the company had an Operating Margin of 16.71%.
Operating Margin history for Bristol-Myers Squibb from 2001 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | 16.71% | -4.29% |
| 2021 | 17.46% | -208.03% |
| 2020 | -16.16% | -184.93% |
| 2019 | 19.03% | -28.57% |
| 2018 | 26.64% | 7.86% |
| 2017 | 24.70% | -18.89% |
| 2016 | 30.45% | 132.68% |
| 2015 | 13.09% | -12.73% |
| 2014 | 14.99% | -15.02% |
| 2013 | 17.64% | 32.87% |
| 2012 | 13.28% | -59.59% |
| 2011 | 32.86% | 5.46% |
| 2010 | 31.16% | 4.61% |
| 2009 | 29.79% | 12.13% |
| 2008 | 26.56% | 45.42% |
| 2007 | 18.27% | 24.18% |
| 2006 | 14.71% | -37.44% |
| 2005 | 23.51% | 3.14% |
| 2004 | 22.80% | 1.47% |
| 2003 | 22.47% | 53.78% |
| 2002 | 14.61% | -2.02% |
| 2001 | 14.91% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 22.88% | 18.92% | 🇺🇸 USA |
 Novartis NVS | 17.27% | -10.24% | 🇨🇭 Switzerland |
 Pfizer PFE | 34.61% | 79.89% | 🇺🇸 USA |
 AbbVie ABBV | 18.65% | -3.07% | 🇺🇸 USA |
 Eli Lilly LLY | 24.66% | 28.17% | 🇺🇸 USA |
 Amgen AMGN | 34.59% | 79.78% | 🇺🇸 USA |
 Sanofi SNY | 18.21% | -5.35% | 🇫🇷 France |
 Biogen BIIB | 31.30% | 62.68% | 🇺🇸 USA |
 Merck MRK | 27.73% | 44.13% | 🇺🇸 USA |
 AstraZeneca AZN | 5.63% | -70.74% | 🇬🇧 UK |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.